Clinical trial
Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis)
NCT01376154 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis)
- Lead sponsor
- GlaxoSmithKline
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2006
- Completion date
- February 28, 2011
- Enrollment
- 342 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.